Literature DB >> 24276757

Image acquisition and interpretation criteria for 99mTc-HMPAO-labelled white blood cell scintigraphy: results of a multicentre study.

Paola A Erba1, Andor W J M Glaudemans, Niels C Veltman, Martina Sollini, Marta Pacilio, Filippo Galli, Rudi A J O Dierckx, Alberto Signore.   

Abstract

PURPOSE: There is no consensus yet on the best protocol for planar image acquisition and interpretation of radiolabelled white blood cell (WBC) scintigraphy. This may account for differences in reported diagnostic accuracy amongst different centres.
METHODS: This was a multicentre retrospective study analysing 235 WBC scans divided into two groups. The first group of scans (105 patients) were acquired with a fixed-time acquisition protocol and the second group (130 patients) were acquired with a decay time-corrected acquisition protocol. Planar images were interpreted both qualitatively and semiquantitatively. Three blinded readers analysed the images.
RESULTS: The most accurate imaging acquisition protocol comprised image acquisition at 3 - 4 h and at 20 - 24 h in time mode with acquisition times corrected for isotope decay.
CONCLUSION: Using this protocol, visual analysis had high sensitivity and specificity in the diagnosis of infection. Semiquantitative analysis could be used in doubtful cases, with no cut-off for the percentage increase in radiolabelled WBC over time, as a criterion to define a positive scan.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24276757     DOI: 10.1007/s00259-013-2631-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

Review 1.  The molecular imaging approach to image infections and inflammation by nuclear medicine techniques.

Authors:  Alberto Signore; Andor W J M Glaudemans
Journal:  Ann Nucl Med       Date:  2011-08-12       Impact factor: 2.668

2.  Contribution of systematic serological testing in diagnosis of infective endocarditis.

Authors:  D Raoult; J P Casalta; H Richet; M Khan; E Bernit; C Rovery; S Branger; F Gouriet; G Imbert; E Bothello; F Collart; G Habib
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?

Authors:  Demetrio Familiari; Andor W J M Glaudemans; Valeria Vitale; Daniela Prosperi; Oreste Bagni; Andrea Lenza; Marco Cavallini; Francesco Scopinaro; Alberto Signore
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

Review 4.  Prosthetic joint infections: radionuclide state-of-the-art imaging.

Authors:  Filip Gemmel; Hans Van den Wyngaert; Charito Love; M M Welling; Paul Gemmel; Christopher J Palestro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-24       Impact factor: 9.236

5.  Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine.

Authors:  Erik F J de Vries; Manel Roca; Francois Jamar; Ora Israel; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04       Impact factor: 9.236

6.  Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis.

Authors:  Paola A Erba; Umberto Conti; Elena Lazzeri; Martina Sollini; Roberta Doria; Salvatore M De Tommasi; Francesco Bandera; Carlo Tascini; Francesco Menichetti; Rudi A J O Dierckx; Alberto Signore; Giuliano Mariani
Journal:  J Nucl Med       Date:  2012-07-11       Impact factor: 10.057

7.  Interobserver reproducibility in the interpretation of 99mTc-labelled white blood cell scintigraphic images.

Authors:  Marianne C Tondeur; Alain Sand; Hamphrey H Ham
Journal:  Nucl Med Commun       Date:  2008-12       Impact factor: 1.690

Review 8.  Labeled leukocyte imaging: current status and future directions.

Authors:  C J Palestro; C Love; K K Bhargava
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-02       Impact factor: 2.346

9.  Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications.

Authors:  F R Grippaudo; M Pacilio; M Di Girolamo; R A Dierckx; A Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-04       Impact factor: 9.236

10.  A large retrospective single-centre study to define the best image acquisition protocols and interpretation criteria for white blood cell scintigraphy with ⁹⁹mTc-HMPAO-labelled leucocytes in musculoskeletal infections.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Liliane E M Vermeulen; Riemer H J A Slart; Rudi A J O Dierckx; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-17       Impact factor: 9.236

View more
  15 in total

1.  Comment on Aksoy et al.: FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection.

Authors:  Elena Lazzeri; Ora Israel; Paola A Erba; Riddhika Chakravartty; Josè Martin Comin; Francois Jamar; Francois Rouzet; Andor W J M Glaudemans; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-07       Impact factor: 9.236

Review 2.  Diagnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Luca Maria Sconfienza; Alberto Signore; Victor Cassar-Pullicino; Maria Adriana Cataldo; Olivier Gheysens; Olivier Borens; Andrej Trampuz; Klaus Wörtler; Nicola Petrosillo; Heinz Winkler; Filip M H M Vanhoenacker; Paul C Jutte; Andor W J M Glaudemans
Journal:  Eur Radiol       Date:  2019-06-27       Impact factor: 5.315

3.  Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection.

Authors:  Johan Teiler; Börje Åkerlund; Harald Brismar; Irina Savitcheva; Marcus Ahl; Annie Bjäreback; Håkan Hedlund; Maria Holstensson; Rimma Axelsson
Journal:  Nucl Med Commun       Date:  2021-07-01       Impact factor: 1.690

4.  Imaging infection and inflammation.

Authors:  Alberto Signore; Andor W J M Glaudemans; Filippo Galli; François Rouzet
Journal:  Biomed Res Int       Date:  2015-03-24       Impact factor: 3.411

5.  Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline.

Authors:  A Signore; F Jamar; O Israel; J Buscombe; J Martin-Comin; E Lazzeri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-31       Impact factor: 9.236

6.  Study of Binding Kinetics and Specificity of 99mTc-SSS-Complex and 99mTc-HMPAO to Blood Cells.

Authors:  S Auletta; V Iodice; F Galli; N Lepareur; A Devillers; A Signore
Journal:  Contrast Media Mol Imaging       Date:  2018-10-25       Impact factor: 3.161

7.  Labelling and Clinical Performance of Human Leukocytes Labelled with 99mTc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent.

Authors:  S Auletta; D Riolo; M Varani; C Lauri; F Galli; A Signore
Journal:  Contrast Media Mol Imaging       Date:  2019-03-25       Impact factor: 3.161

8.  Consensus document for the diagnosis of peripheral bone infection in adults: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Andor W J M Glaudemans; Paul C Jutte; Maria Adriana Cataldo; Victor Cassar-Pullicino; Olivier Gheysens; Olivier Borens; Andrej Trampuz; Klaus Wörtler; Nicola Petrosillo; Heinz Winkler; Alberto Signore; Luca Maria Sconfienza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-24       Impact factor: 9.236

Review 9.  Nuclear medicine imaging of posttraumatic osteomyelitis.

Authors:  G A M Govaert; A W J M Glaudemans
Journal:  Eur J Trauma Emerg Surg       Date:  2016-02-17       Impact factor: 3.693

10.  Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Alberto Signore; Luca Maria Sconfienza; Olivier Borens; Andor W J M Glaudemans; Victor Cassar-Pullicino; Andrej Trampuz; Heinz Winkler; Olivier Gheysens; Filip M H M Vanhoenacker; Nicola Petrosillo; Paul C Jutte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-26       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.